title: [Acetylsalicylic acid consumption in patients with diabetes mellitus].
abstract: OBJECTIVE
  Acetylsalicylic acid (ASA) has been recommended for primary (PP) and secondary prevention (SP) of cardiovascular disease (CVD) in diabetic patients. The consumption of ASA among Catalan diabetic people is described here.
  
  
  METHODS
  We analyzed 1,718 questionnaires administered to members of the Catalonia's Diabetic Association. ASA intake, history of CVD and medical advice about the use of ASA were evaluated.
  
  
  RESULTS
  ASA was taken by 21% subjects (as PP in 14% and as SP in 53%). Medical advice had been received in 23% (15% as PP and 56% as SP).
  
  
  CONCLUSIONS
  ASA intake among diabetic patients is low in both PP and SP. Physicians should recommend its use to improve this situation.
authors.affiliation: Societat Catalana de Diabetis. Barcelona. Spain. esmatjes@clinic.ub.es
authors.forename: Enric
authors.initials: E
authors.lastname: Esmatjes
authors.forename: Conxa
authors.initials: C
authors.lastname: Castell
authors.forename: Josep
authors.initials: J
authors.lastname: Franch
authors.forename: Emma
authors.initials: E
authors.lastname: Puigoriol
authors.forename: Rubén
authors.initials: R
authors.lastname: Hernáez
mesh_terms: D000328:Adult; D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin